Evaluation of Artificial Intelligence in Participating Structure-Based Virtual Screening for Identifying Novel Interleukin-1 Receptor Associated Kinase-1 Inhibitors-Reference-Cited by-同舟云学术

Evaluation of Artificial Intelligence in Participating Structure-Based Virtual Screening for Identifying Novel Interleukin-1 Receptor Associated Kinase-1 Inhibitors

Published:2020-09-03 Issue: Volume:10 Page:
ISSN:2234-943X
Container-title:Frontiers in Oncology
language:
Short-container-title:Front. Oncol.

Author:

Che Jinxin,Feng Ruiwei,Gao Jian,Yu Hongyun,Weng Qinjie,He Qiaojun,Dong Xiaowu,Wu Jian,Yang Bo

Funder

National Natural Science Foundation of China

China Postdoctoral Science Foundation

Publisher

Frontiers Media SA

Subject

Cancer Research,Oncology

Reference31 articles.

1. Integration of virtual and high-throughput screening.;Bajorath;Nat Rev Drug Discov.,2002

2. Virtual ligand screening: strategies, perspectives and limitations.;Klebe;Drug Discov Today.,2006

3. Virtual screening techniques in drug discovery: review and recent applications.;Rocha;Curr Top Med Chem.,2019

4. Structure-based virtual screening approaches in kinase-directed drug discovery.;Bajusz;Curr Top Med Chem.,2017

5. A critical assessment of docking programs and scoring functions.;Warren;J Med Chem.,2006

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Discovery of novel ULK1 inhibitors through machine learning-guided virtual screening and biological evaluation;Future Medicinal Chemistry;2024-08-15

2. Revolution of Artificial Intelligence in Computational Chemistry Breakthroughs;Chemistry Africa;2024-05-31

3. Multiple Factors Determine the Oncolytic or Carcinogenic Effects of TLRs Activation in Cancer;Journal of Immunology Research;2024-01-13

4. Nitro Compounds Inhibit Breast Cancer Cell Proliferation, Migration, and Colony Formation: Molecular Docking, Molecular Dynamics Simulations and Pharmacological Properties;ChemistrySelect;2023-12-21

5. Identification of Potential JNK3 Inhibitors: A Combined Approach Using Molecular Docking and Deep Learning-Based Virtual Screening;Pharmaceuticals;2023-10-13